Apollo Adlux Hospital's Department of Medical Genetics is a specialised centre in Angamaly, Kerala, dedicated to diagnosing, managing, and counselling patients and families affected by genetic and inherited disorders. The department offers services spanning prenatal genetics, paediatric rare disease diagnosis, neurogenetics, oncogenetics, and advanced genomic testing including exome and genome sequencing.

A medical genetics department evaluates and manages a wide range of conditions including chromosomal abnormalities (Down syndrome, Turner syndrome), inborn errors of metabolism (PKU, MSUD, organic acidaemias), rare genetic syndromes, hereditary cancers (BRCA mutations, Lynch syndrome), neurogenetic disorders (muscular dystrophy, ataxias), and conditions identified through newborn screening or prenatal genetic testing.

Medical geneticists have specialised training in diagnosing conditions with genetic causes that may be missed by general physicians. They can interpret complex genetic tests, identify the root cause of rare or unusual symptoms, and provide accurate recurrence risk assessments and family counselling — helping patients and families make informed decisions about treatment and future pregnancies.

Yes. Apollo Adlux Hospital in Angamaly, Ernakulam district, Kerala, houses a dedicated Department of Medical Genetics offering comprehensive genetic services including genetic counselling, chromosomal testing, molecular diagnostics, prenatal genetics, paediatric rare disease diagnosis, neurogenetics, and oncogenetics.

Yes. All genetic counselling at Apollo Adlux Hospital is strictly confidential. Your genetic information and test results are protected by medical privacy regulations and will not be shared without your explicit consent, except in legally mandated circumstances.

Dysmorphology is the study and clinical assessment of structural differences or unusual physical features (dysmorphic features) that may indicate an underlying genetic syndrome. A dysmorphology assessment at Apollo Adlux involves a detailed physical examination by a clinical geneticist who analyses features such as facial structure, body proportions, skin, hands, and other physical characteristics to identify patterns consistent with known genetic conditions.

A neurogenetic disorder is a condition caused by a genetic mutation that primarily affects the function of the nervous system and/or muscles. Examples include Duchenne muscular dystrophy, Becker muscular dystrophy, spinocerebellar ataxias, Friedreich ataxia, Charcot-Marie-Tooth disease, Huntington disease, hereditary spastic paraplegia, and spinal muscular atrophy (SMA). Neurogenetic disorders may present in childhood or adulthood and are often progressive.

Yes, muscular dystrophies are inherited genetic disorders caused by mutations in genes responsible for producing proteins essential for muscle function. Duchenne and Becker muscular dystrophy are caused by mutations in the DMD gene and follow an X-linked inheritance pattern. Other forms, such as Limb-Girdle muscular dystrophy, can be inherited in autosomal dominant or autosomal recessive patterns. Genetic testing can confirm the type of muscular dystrophy and guide family counselling.

Oncogenetics (hereditary cancer genetics) is the study and clinical management of cancers with a genetic (inherited) basis. Approximately 5–10% of all cancers are hereditary, meaning they are caused by inherited mutations in specific genes that significantly increase cancer risk. Common examples include BRCA1 and BRCA2 gene mutations (associated with hereditary breast and ovarian cancer) and Lynch syndrome mutations (associated with hereditary colorectal cancer).

If you test positive for a hereditary cancer gene mutation, Apollo Adlux's oncogenetics team will work with you to develop a personalised surveillance and prevention plan. Options may include: enhanced screening (more frequent mammography, MRI, or colonoscopy); risk-reducing medications (chemoprevention); risk-reducing surgery; and genetic counselling for family members who may also carry the mutation and benefit from testing.